• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides.碳水化合物结合蛋白35。二、重组多肽与糖类相互作用的分析。
J Biol Chem. 1993 Jul 15;268(20):14940-7.
2
Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.关于半乳糖凝集素中参与寡糖配体中心半乳糖非还原端糖结合的亚位点的证据:仓鼠半乳糖凝集素-3的序列分析、同源建模和诱变研究。
Glycobiology. 1998 Jan;8(1):45-57. doi: 10.1093/glycob/8.1.45.
3
Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation.半乳糖凝集素-5与游离糖类和哺乳动物糖蛋白的相互作用概况:探究其精细特异性及天然簇状配体呈现的影响。
Glycobiology. 2006 Jun;16(6):524-37. doi: 10.1093/glycob/cwj102. Epub 2006 Mar 15.
4
Lewis X-containing glycans are specific and potent competitive inhibitors of the binding of ZP3 to complementary sites on capacitated, acrosome-intact mouse sperm.含有Lewis X的聚糖是ZP3与获能的、顶体完整的小鼠精子上互补位点结合的特异性强效竞争性抑制剂。
Biol Reprod. 2004 Sep;71(3):770-7. doi: 10.1095/biolreprod.103.023812. Epub 2004 May 5.
5
Defining carbohydrate specificity of Ricinus communis agglutinin as Gal beta 1-->4GlcNAc (II) > Gal beta 1-->3GlcNAc (I) > Gal alpha 1-->3Gal (B) > Gal beta 1-->3GalNAc (T).将蓖麻凝集素的碳水化合物特异性定义为:β-半乳糖基-1,4-N-乙酰葡糖胺(II型)>β-半乳糖基-1,3-N-乙酰葡糖胺(I型)>α-半乳糖基-1,3-半乳糖(B型)>β-半乳糖基-1,3-N-乙酰半乳糖胺(T型) 。
Mol Immunol. 1993 Mar;30(4):333-9. doi: 10.1016/0161-5890(93)90062-g.
6
Isolation and characterization of amaranthin, a lectin present in the seeds of Amaranthus caudatus, that recognizes the T- (or cryptic T)-antigen.尾穗苋种子中存在的一种识别T抗原(或隐蔽T抗原)的凝集素——苋红素的分离与特性鉴定。
J Biol Chem. 1989 Sep 25;264(27):16123-31.
7
Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.人类血型H基因指定的α1,2-L-岩藻糖基转移酶对硫酸化/唾液酸化/岩藻糖基化受体的特异性表征:Gal的α1,2-L-岩藻糖基化与天冬酰胺连接的GlcNAc的α1,6-L-岩藻糖基化之间呈负相关的证据。
Biochemistry. 1996 Jul 9;35(27):8914-24. doi: 10.1021/bi952193m.
8
Human serum contains a novel beta 1,6-N-acetylglucosaminyltransferase activity that is involved in midchain branching of oligo (N-acetyllactosaminoglycans).人血清含有一种新型的β1,6-N-乙酰葡糖胺基转移酶活性,其参与寡聚(N-乙酰乳糖胺聚糖)的中间链分支。
Biochemistry. 1991 Sep 24;30(38):9287-96. doi: 10.1021/bi00102a022.
9
Murine sperm-zona binding, a fucosyl residue is required for a high affinity sperm-binding ligand. A second site on sperm binds a nonfucosylated, beta-galactosyl-capped oligosaccharide.在小鼠精子与透明带结合过程中,高亲和力精子结合配体需要一个岩藻糖基残基。精子上的第二个位点结合一种非岩藻糖基化的、β-半乳糖基封端的寡糖。
J Biol Chem. 1998 Jan 23;273(4):1888-95. doi: 10.1074/jbc.273.4.1888.
10
Molecular mimicry in the recognition of glycosphingolipids by Gal alpha 3 Gal beta 4 GlcNAc beta-binding Clostridium difficile toxin A, human natural anti alpha-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor.由Galα3Galβ4GlcNAcβ结合的艰难梭菌毒素A、人类天然抗α-半乳糖基IgG和单克隆抗体Gal-13识别糖鞘脂中的分子模拟:一种与动物受体不同的具有结合活性的人类糖鞘脂的特性
Glycobiology. 1996 Sep;6(6):599-609. doi: 10.1093/glycob/6.6.599.

引用本文的文献

1
F Fast Magic-Angle Spinning NMR Spectroscopy on Microcrystalline Complexes of Fluorinated Ligands and the Carbohydrate Recognition Domain of Galectin-3.快速魔角旋转 NMR 光谱法研究氟化配体与半乳凝集素-3 碳水化合物识别结构域的微晶配合物。
Biochemistry. 2024 Sep 3;63(17):2207-2216. doi: 10.1021/acs.biochem.4c00232. Epub 2024 Jul 15.
2
-linked glycans: an underappreciated key determinant of T cell development, activation, and function.N-连接聚糖:T细胞发育、激活和功能中一个未被充分认识的关键决定因素。
Immunometabolism (Cobham). 2023 Nov 21;5(4):e00035. doi: 10.1097/IN9.0000000000000035. eCollection 2023 Oct.
3
Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides.
解析人源半乳糖凝集素与角膜角蛋白硫酸酯、其去硫酸化形式及相关糖结合的结构。
Sci Rep. 2020 Sep 24;10(1):15708. doi: 10.1038/s41598-020-72645-9.
4
Galectin-Glycan Interactions: Guidelines for Monitoring by Se NMR Spectroscopy, and Solvent (H O/D O) Impact on Binding.半乳糖凝集素-聚糖相互作用:通过 1 H NMR 光谱监测的指南,以及溶剂(H 2 O/D 2 O)对结合的影响。
Chemistry. 2021 Jan 4;27(1):316-325. doi: 10.1002/chem.202003143. Epub 2020 Dec 2.
5
Influence of protein (human galectin-3) design on aspects of lectin activity.蛋白质(人半乳糖凝集素-3)设计对凝集素活性的影响。
Histochem Cell Biol. 2020 Aug;154(2):135-153. doi: 10.1007/s00418-020-01859-9. Epub 2020 Apr 25.
6
Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.半乳糖凝集素-3:肺动脉高压中活性氧、纤维化和炎症的先兆。
Antioxid Redox Signal. 2019 Nov 10;31(14):1053-1069. doi: 10.1089/ars.2019.7753. Epub 2019 Mar 29.
7
Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail.人源半乳糖凝集素-3 变体在缩短的 N 端尾部的两个有序片段的结晶。
Sci Rep. 2018 Jun 29;8(1):9835. doi: 10.1038/s41598-018-28235-x.
8
Synthetic glycoconjugates inhibitors of tumor-related galectin-3: an update.肿瘤相关半乳糖凝集素-3的合成糖缀合物抑制剂:最新进展
Glycoconj J. 2016 Dec;33(6):853-876. doi: 10.1007/s10719-016-9721-z. Epub 2016 Aug 15.
9
Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition.多价碳水化合物-凝集素相互作用:合成化学如何助力洞察纳米级识别。
Molecules. 2016 May 13;21(5):629. doi: 10.3390/molecules21050629.
10
Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.人半乳糖凝集素-3的分子内和分子间相互作用:基于完全归属的核磁共振评估
Glycobiology. 2016 Aug;26(8):888-903. doi: 10.1093/glycob/cww021. Epub 2016 Feb 23.

碳水化合物结合蛋白35。二、重组多肽与糖类相互作用的分析。

Carbohydrate-binding protein 35. II. Analysis of the interaction of the recombinant polypeptide with saccharides.

作者信息

Knibbs R N, Agrwal N, Wang J L, Goldstein I J

机构信息

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor 48109-0606.

出版信息

J Biol Chem. 1993 Jul 15;268(20):14940-7.

PMID:8325871
Abstract

The carbohydrate binding specificity of recombinant carbohydrate-binding protein 35 (rCBP35) has been investigated by quantitative precipitation using a series of glycoproteins and carbohydrate-protein conjugates and by inhibition of precipitation using well defined carbohydrate haptens. Synthetic glycoconjugates and glycoproteins containing terminal nonreducing galactosyl units in beta-linkage were capable of forming a precipitate with rCBP35. If the glycoprotein or glycoconjugate contained terminal Neu5Ac, or galactose in alpha-linkage, precipitate formation was not observed. We also found that murine laminin, which contains polylactosamine structures, reacted more strongly than did bovine fetuin. Using carbohydrate-bovine serum albumin (BSA) glycoconjugates, we found that the tetrasaccharide Gal beta 1, 4GlcNAc beta 1, 3Gal beta 1,4-GlcNAc-BSA reacted more strongly than the disaccharide Gal beta 1, 4GlcNAc-BSA conjugate, suggesting that the binding site accommodates carbohydrate ligands greater in size than a disaccharide. Equilibrium dialysis experiments using [3H]lactose showed that rCBP35 binds 1 mol (n = 0.84) of lactose/30,000 g atoms of protein, with an affinity constant of 2.07 x 10(4) M-1. The binding site on the polypeptide appears to contain four subsites that recognize the sequence Gal beta 1,4GlcNAc beta 1, Gal beta 1,X-. All disaccharides tested that contain a nonreducing beta-galactosyl unit behaved as inhibitors of precipitation at approximately the same concentration, suggesting that the reducing position of the tetrasaccharide does not play an important role in the specific binding to the fourth subsite. The reducing sugar may serve to hold the saccharide in a tunnel like binding pocket since methyl-beta-D-galactoside itself is an extremely poor inhibitor.

摘要

通过使用一系列糖蛋白和碳水化合物 - 蛋白质缀合物进行定量沉淀,以及使用明确的碳水化合物半抗原抑制沉淀,研究了重组碳水化合物结合蛋白35(rCBP35)的碳水化合物结合特异性。含有β-连接的末端非还原半乳糖基单元的合成糖缀合物和糖蛋白能够与rCBP35形成沉淀。如果糖蛋白或糖缀合物含有末端Neu5Ac或α-连接的半乳糖,则未观察到沉淀形成。我们还发现,含有聚乳糖胺结构的小鼠层粘连蛋白比牛胎球蛋白反应更强。使用碳水化合物 - 牛血清白蛋白(BSA)糖缀合物,我们发现四糖Galβ1,4GlcNAcβ1,3Galβ1,4 - GlcNAc - BSA比二糖Galβ1,4GlcNAc - BSA缀合物反应更强,这表明结合位点容纳的碳水化合物配体大小大于二糖。使用[3H]乳糖的平衡透析实验表明,rCBP35结合1摩尔(n = 0.84)乳糖/30,000克原子蛋白质,亲和常数为2.07×10(4) M-1。多肽上的结合位点似乎包含四个亚位点,可识别序列Galβ1,4GlcNAcβ1,Galβ1,X - 。所有测试的含有非还原β-半乳糖基单元的二糖在大约相同浓度下均表现为沉淀抑制剂,这表明四糖的还原位置在与第四亚位点的特异性结合中不起重要作用。还原糖可能用于将糖类保持在类似隧道的结合口袋中,因为甲基 - β-D - 半乳糖苷本身是一种极差的抑制剂。